{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:36:00Z","timestamp":1788816960451,"version":"build-2803163510"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,1,16]]},"abstract":"<jats:p>This JAMA Insights describes indications for naloxone use in preventing opioid overdoses and benefits vs barriers to its availability following FDA approval of its availability without a prescription.<\/jats:p>","DOI":"10.1001\/jama.2023.23248","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:00:48Z","timestamp":1703174448000},"page":"250","source":"Crossref","is-referenced-by-count":10,"title":["Intranasal Naloxone for Opioid Overdose"],"prefix":"10.1001","volume":"331","author":[{"given":"Jessica L.","family":"Taylor","sequence":"first","affiliation":[{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts"},{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Lasser","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts"},{"name":"Senior Editor, JAMA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"jit230021r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14977","article-title":"Effect of intranasal vs intramuscular naloxone on opioid overdose: a randomized clinical trial.","volume":"2","author":"Dietze","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"8","key":"jit230021r3","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2105\/AJPH.2021.306306a","article-title":"The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews.","volume":"111","author":"Razaghizad","year":"2021","journal-title":"Am J Public Health"},{"issue":"1","key":"jit230021r4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40621-015-0041-8","article-title":"Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis.","volume":"2","author":"Giglio","year":"2015","journal-title":"Inj Epidemiol"},{"key":"jit230021r5","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"jit230021r6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain.","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"key":"jit230021r7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajem.2021.12.030","article-title":"Naloxone-associated pulmonary edema following recreational opioid overdose.","volume":"53","author":"Kummer","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"1","key":"jit230021r8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications.","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"jit230021r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"jit230021r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100052","article-title":"What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? using multiplier approaches to estimate prevalence for an unknown population size.","volume":"3","author":"Keyes","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"jit230021r1","unstructured":"National Institute on Drug Abuse. Drug overdose death rates. Published February 9, 2023. Accessed June 13, 2023. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2813503\/jama_taylor_2023_it_230021_1704388777.87982.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T16:02:37Z","timestamp":1705420957000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2813503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,1,16]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.23248","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,16]]}}}